sang et organes humains – Souveraineté sanitaire : fabrication de médicaments dérivés du plasma

This written question concerns the national sovereignty in the production of medicines derived from human blood plasma. It highlights concerns about the security of supply for these vital treatments. The question seeks to understand the government's strategy to ensure domestic production capacity and reduce reliance on external sources for plasma-derived medicines.